
Sign up to save your podcasts
Or


This was a collaboration with the National Lipid Association's Lipid Insights podcast. You can listen to more Lipid Insights on Apple Podcasts or Spotify.
Michael J. Wilkinson, MD, FACC, FNLA, is an associate professor of medicine and director of the advanced lipid treatment program at UC San Diego Health. You can find him on Linkedin.
Dr. Morris and Dr. Beavers discuss the 2026 American College of Cardiology (ACC) expert consensus decision pathway for heart failure with preserved ejection fraction (HFpEF), published in the Journal of the American College of Cardiology. You can read the report here.
About the Guest
Alanna Morris, MD, MSc, is a heart failure cardiologist and the Executive Medical Director, US Medical Affairs at Bayer.
Upcoming Meeting
The Heart Failure Society of America Annual Scientific Meeting 2026 takes place October 9–12, 2026, in Phoenix, Arizona.
CARDIO-TTRansform — eplontersen in transthyretin amyloid cardiomyopathy (ATTR-CM).
ClinicalTrials.gov: NCT04136171
SINGLE-AF — direct oral anticoagulation in patients with atrial fibrillation at intermediate stroke risk.
ClinicalTrials.gov: NCT04437654
POET II — response-tailored, shortened antibiotic therapy in left-sided infective endocarditis.
ClinicalTrials.gov: NCT03851575
From the publisher's feed